Complete Filing Data
Arcturus Therapeutics Holdings Inc. reported Stockholders Equity of $213.99 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Arcturus Therapeutics Holdings Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$65.8M | -$80.9M | -$29.7M | $9.3M | -$203.7M | -$72.1M | -$26.0M | -$21.8M |
| Revenue From Contract With Customer Excluding Assessed Tax | $82.0M | $152.3M | $166.8M | $206.0M | $12.4M | $9.5M | $20.8M | $15.8M |
| Research And Development Expense | $112.2M | $195.2M | $192.1M | $147.8M | $173.8M | $57.8M | $33.6M | $17.0M |
| Operating Income Loss | -$76.3M | -$95.7M | -$78.2M | $12.2M | -$202.9M | -$71.5M | -$25.5M | -$21.8M |
| General And Administrative Expense | $46.1M | $52.8M | $52.9M | $46.1M | $41.5M | $23.2M | $12.7M | $20.6M |
| Other Nonoperating Income Expense | $10.1M | $15.2M | $16.6M | -$420.0K | -$1.9M | -$361.0K | -$446.0K | $328.0K |
| Operating Expenses | $158.3M | $248.0M | $245.0M | $193.8M | $215.2M | $81.1M | $46.3M | $37.6M |
| Comprehensive Income Net Of Tax | -$65.8M | -$80.9M | -$29.7M | $9.3M | -$203.7M | -$72.1M | -$26.0M | -$21.8M |
| Deferred Revenue Current | $8.2M | $19.5M | $44.8M | $28.6M | $43.5M | $18.1M | $8.4M | $6.3M |
| Deferred Revenue Noncurrent | $12.6M | $42.5M | $20.1M | $19.9M | $12.5M | $15.2M | $7.5M | |
| Income Loss From Equity Method Investments | -$515.0K | $515.0K | -$263.0K | -$32.0K | -$302.0K | |||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$65.8M | -$80.9M | -$27.9M | $10.6M | -$203.7M | |||
| Income Tax Expense Benefit | -$4.0K | $1.8M | $1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$13.4M | -$9.2M | -$14.1M | -$6.9M | -$17.2M | -$26.8M | -$16.2M | -$52.6M | $50.8M | -$35.3M | -$21.6M | -$51.2M | -$38.7M | -$54.1M | -$54.6M | -$56.3M | -$31.1M | -$21.0M | -$10.3M | -$9.8M | -$11.0M | -$7.4M | -$685.0K | -$6.9M | -$4.3M | -$10.0M |
| Revenue From Contract With Customer Excluding Assessed Tax | $17.2M | $28.3M | $29.4M | $41.7M | $49.9M | $38.0M | $45.1M | $10.5M | $80.3M | $13.4M | $27.1M | $5.2M | $5.8M | $2.4M | $2.0M | $2.1M | $2.2M | $2.3M | $2.3M | $2.6M | $3.0M | $3.3M | $10.2M | $4.4M | $3.4M | $2.4M |
| Research And Development Expense | $23.3M | $29.6M | $34.9M | $39.1M | $58.7M | $53.6M | $51.1M | $52.7M | $51.8M | $37.7M | $38.2M | $44.9M | $32.6M | $45.4M | $45.7M | $50.1M | $24.3M | $17.7M | $7.9M | $7.9M | $12.0M | $7.1M | $7.3M | $7.3M | $4.0M | $4.2M |
| Operating Income Loss | -$16.5M | -$11.6M | -$16.8M | -$10.7M | -$21.1M | -$30.4M | -$19.3M | -$55.4M | $14.8M | -$36.8M | -$22.1M | -$50.4M | -$37.6M | -$53.8M | -$53.7M | -$57.7M | -$31.1M | -$20.9M | -$10.0M | -$9.5M | -$10.8M | -$7.6M | -$572.0K | -$6.5M | -$4.4M | -$10.1M |
| General And Administrative Expense | $10.4M | $10.3M | $11.3M | $13.3M | $12.3M | $14.9M | $13.4M | $13.2M | $13.8M | $12.5M | $11.0M | $10.7M | $10.8M | $10.9M | $10.0M | $9.7M | $9.0M | $5.6M | $4.4M | $4.2M | $1.8M | $3.9M | $3.5M | $3.5M | $3.8M | $8.2M |
| Other Nonoperating Income Expense | $3.2M | $2.6M | $2.8M | $3.8M | $4.1M | $4.0M | $4.0M | $3.3M | $2.5M | -$321.0K | -$560.0K | -$564.0K | -$519.0K | -$520.0K | -$358.0K | -$66.0K | -$121.0K | -$152.0K | -$120.0K | -$113.0K | -$88.0K | $150.0K | $169.0K | |||
| Operating Expenses | $33.7M | $39.9M | $46.2M | $52.4M | $71.0M | $68.4M | $64.5M | $65.9M | $65.5M | $50.2M | $49.2M | $55.6M | $56.3M | $55.7M | $59.8M | $23.3M | $12.4M | $12.1M | $10.9M | $10.7M | $10.9M | $7.8M | $12.5M | |||
| Comprehensive Income Net Of Tax | -$13.4M | -$9.2M | -$14.1M | -$6.9M | -$17.2M | -$26.8M | -$16.2M | -$52.6M | $50.8M | -$35.3M | -$21.6M | -$51.2M | -$54.1M | -$54.6M | -$56.3M | -$21.0M | -$10.3M | -$9.8M | -$7.4M | -$685.0K | -$6.9M | -$4.3M | -$9.9M | |||
| Deferred Revenue Current | $6.8M | $11.3M | $12.7M | $26.9M | $42.4M | $71.5M | $40.8M | $48.0M | $38.5M | $4.7M | $26.3M | $53.1M | $57.6M | $18.1M | $17.9M | $5.7M | $6.8M | $8.1M | $11.0M | $9.7M | ||||||
| Deferred Revenue Noncurrent | $4.2M | $8.8M | $9.6M | $13.3M | $11.3M | $11.8M | $41.9M | $25.7M | $20.6M | $5.2M | $5.6M | $6.6M | $8.5M | $9.9M | $11.3M | $13.6M | $14.0M | $13.8M | $14.6M | $17.7M | ||||||
| Income Loss From Equity Method Investments | -$131.0K | -$384.0K | -$250.0K | -$328.0K | $1.2M | -$100.0K | -$163.0K | $303.0K | -$288.0K | -$47.0K | -$47.0K | |||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.4M | -$9.2M | -$14.1M | -$7.1M | -$17.4M | -$26.4M | -$15.3M | -$52.0M | $50.9M | -$35.3M | -$21.6M | -$51.2M | ||||||||||||||
| Income Tax Expense Benefit | $4.0K | $0.00 | -$217.0K | -$150.0K | $368.0K | $893.0K | $577.0K | $103.0K | $100.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $214.0M | $241.0M | $278.5M | $270.3M | $228.2M | $396.6M | $25.8M | $13.6M | $33.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $232.8M | $293.9M | $348.9M | $394.0M | $372.6M | $463.0M | $71.5M | $36.8M | $25.2M |
| Restricted Cash Noncurrent | $1.9M | $1.9M | $1.9M | $2.1M | $2.1M | $107.0K | $107.0K | $107.0K | |
| Cash And Cash Equivalents At Carrying Value | $230.9M | $237.0M | $292.0M | $391.9M | $370.5M | $462.9M | $71.4M | $36.7M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$61.1M | -$55.0M | -$45.1M | $21.4M | -$90.4M | $391.5M | $34.6M | $11.6M | |
| Retained Earnings Accumulated Deficit | -$514.6M | -$448.8M | -$367.9M | -$338.1M | -$347.5M | -$143.8M | -$71.7M | -$44.9M | |
| Property Plant And Equipment Net | $6.7M | $9.5M | $12.4M | $12.4M | $5.6M | $3.4M | $2.3M | $2.0M | |
| Prepaid Expenses And Other Receivables | $5.0M | $10.0M | $7.5M | $8.7M | $5.1M | $2.8M | $758.0K | $638.0K | |
| Liabilities Current | $36.4M | $65.5M | $82.0M | $127.0M | $99.5M | $49.5M | $21.3M | $12.6M | |
| Liabilities And Stockholders Equity | $271.1M | $344.1M | $429.4M | $450.4M | $392.8M | $476.5M | $82.1M | $44.2M | |
| Liabilities | $57.2M | $103.1M | $150.9M | $180.1M | $164.6M | $79.9M | $56.4M | $30.6M | |
| Common Stock Value | $28.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $15.0K | $214.0K | |
| Assets Current | $241.4M | $306.0M | $386.6M | $403.3M | $379.0M | $467.8M | $74.3M | $41.8M | |
| Assets | $271.1M | $344.1M | $429.4M | $450.4M | $392.8M | $476.5M | $82.1M | $44.2M | |
| Accrued Liabilities Current | $23.9M | $38.8M | $31.9M | $30.2M | $23.5M | $19.4M | $7.1M | $3.9M | |
| Accounts Receivable Net Current | $5.6M | $4.0M | $32.1M | $2.8M | $3.4M | $2.1M | $2.2M | $4.5M | |
| Accounts Payable Current | $4.2M | $7.2M | $5.3M | $7.4M | $10.1M | $10.8M | $5.8M | $2.4M | |
| Operating Lease Right Of Use Asset | $21.1M | $26.7M | $28.5M | $32.5M | $5.6M | $5.2M | $5.1M | ||
| Operating Lease Liability Noncurrent | $20.8M | $25.0M | $25.9M | $30.2M | $4.5M | $4.0M | $4.9M | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.7M | $30.2M | $1.8M | $1.4M | $5.9M | ||||
| Long Term Debt Noncurrent | $40.6M | $13.8M | $15.0M | $9.9M | |||||
| Increase Decrease Operating Lease Right Of Use Asset | -$3.7M | -$4.6M | -$4.0M | -$3.3M | -$1.4M | ||||
| Stock Issued During Period Value Under Equity Plan | $585.0K | $682.0K | $609.0K | $411.0K | $515.0K | ||||
| Equity Method Investments | $515.0K | $263.0K | $288.0K | ||||||
| Repayments Of Debt | $15.0M | $47.4M | $5.0M | ||||||
| Other Liabilities Noncurrent | $497.0K | $2.8M | |||||||
| Long Term Debt Current | $60.7M | $22.5M | $1.3M | ||||||
| Restricted Cash Current | $55.0M | $55.0M | |||||||
| Restricted Cash | $55.0M | $55.0M | |||||||
| Non Cash Asset Disposal | $2.3M | $473.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $224.6M | $231.1M | $233.8M | $261.9M | $258.6M | $264.0M | $280.1M | $285.2M | $329.2M | $145.7M | $170.7M | $184.7M | $259.1M | $305.6M | $352.6M | $261.6M | $93.4M | $17.0M | $35.9M | $21.6M | $6.4M | $14.2M | $17.8M | $27.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $237.2M | $253.4M | $273.8M | $294.1M | $317.2M | $345.3M | $369.1M | $380.6M | $330.1M | $239.8M | $285.6M | $321.8M | $416.0M | $433.7M | $466.9M | $307.1M | $136.2M | $59.6M | $74.3M | $55.9M | $31.3M | $30.4M | $29.4M | |
| Restricted Cash Noncurrent | $1.9M | $1.9M | $18.4M | $1.9M | $1.9M | $1.9M | $22.1M | $2.1M | $2.1M | $2.1M | $2.1M | $2.1M | $2.1M | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | $107.0K | |
| Cash And Cash Equivalents At Carrying Value | $180.4M | $196.5M | $216.9M | $237.2M | $260.3M | $288.4M | $311.9M | $323.5M | $327.9M | $237.7M | $283.5M | $319.7M | $413.9M | $433.6M | $466.8M | $307.0M | $136.1M | $59.5M | $74.2M | $55.8M | $31.2M | $30.3M | $29.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$20.1M | -$3.6M | -$63.9M | -$50.8M | $3.9M | -$11.9M | -$5.5M | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$485.5M | -$472.1M | -$462.9M | -$418.8M | -$411.9M | -$394.7M | -$356.2M | -$339.9M | -$287.4M | -$455.5M | -$420.2M | -$398.7M | -$308.8M | -$254.7M | -$200.2M | -$112.7M | -$91.7M | -$81.4M | -$60.7M | -$53.2M | ||||
| Property Plant And Equipment Net | $7.4M | $8.1M | $8.9M | $10.4M | $11.2M | $11.8M | $12.7M | $12.7M | $12.6M | $11.3M | $9.0M | $7.5M | $4.8M | $3.4M | $3.4M | $3.5M | $2.6M | $2.6M | $2.1M | $2.0M | ||||
| Prepaid Expenses And Other Receivables | $5.9M | $5.8M | $8.8M | $8.4M | $7.6M | $5.3M | $8.1M | $4.0M | $4.1M | $7.0M | $5.8M | $3.6M | $5.1M | $2.3M | $1.2M | $4.6M | $3.1M | $1.9M | $2.6M | $1.7M | ||||
| Liabilities Current | $31.7M | $46.5M | $49.4M | $69.5M | $91.7M | $115.4M | $87.7M | $90.3M | $90.1M | $75.8M | $92.7M | $107.3M | $118.2M | $70.8M | $53.3M | $28.0M | $23.0M | $21.7M | $21.7M | $16.4M | ||||
| Liabilities And Stockholders Equity | $282.3M | $309.3M | $331.8M | $370.7M | $388.6M | $418.8M | $457.7M | $430.6M | $470.9M | $293.6M | $337.0M | $342.0M | $434.5M | $448.8M | $481.5M | $322.5M | $149.9M | $72.1M | $87.2M | $70.9M | ||||
| Liabilities | $57.8M | $78.2M | $98.0M | $108.8M | $130.0M | $154.9M | $177.6M | $145.5M | $141.6M | $148.0M | $166.3M | $157.2M | $175.4M | $143.2M | $128.9M | $60.9M | $56.5M | $55.1M | $51.3M | $49.3M | ||||
| Common Stock Value | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $27.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $26.0K | $25.0K | $21.0K | $15.0K | $15.0K | $13.0K | ||||
| Assets Current | $249.2M | $274.5M | $278.8M | $330.8M | $347.0M | $375.8M | $393.3M | $385.2M | $424.6M | $246.7M | $291.5M | $327.0M | $421.0M | $438.0M | $470.0M | $314.1M | $142.0M | $63.8M | $79.4M | $63.3M | ||||
| Assets | $282.3M | $309.3M | $331.8M | $370.7M | $388.6M | $418.8M | $457.7M | $430.6M | $470.9M | $293.6M | $337.0M | $342.0M | $434.5M | $448.8M | $481.5M | $322.5M | $149.9M | $72.1M | $87.2M | $70.9M | ||||
| Accrued Liabilities Current | $19.4M | $24.6M | $30.6M | $32.4M | $35.5M | $34.8M | $28.6M | $28.8M | $32.3M | $25.5M | $33.6M | $20.0M | $52.4M | $42.6M | $29.8M | $15.8M | $11.9M | $9.8M | $6.7M | $3.5M | ||||
| Accounts Receivable Net Current | $8.0M | $17.2M | $14.6M | $30.2M | $24.1M | $27.1M | $38.2M | $2.8M | $92.5M | $2.0M | $2.2M | $3.7M | $2.0M | $2.2M | $2.0M | $2.4M | $2.8M | $2.4M | $2.6M | $5.8M | ||||
| Accounts Payable Current | $5.5M | $10.6M | $6.2M | $10.1M | $13.9M | $9.1M | $18.4M | $13.6M | $19.3M | $18.0M | $5.8M | $10.0M | $8.3M | $10.1M | $5.6M | $6.5M | $4.4M | $3.8M | $4.0M | $3.2M | ||||
| Operating Lease Right Of Use Asset | $23.8M | $24.8M | $25.7M | $27.6M | $28.5M | $29.4M | $29.5M | $30.6M | $31.6M | $33.5M | $34.5M | $5.2M | $6.0M | $6.3M | $6.7M | $4.9M | $5.2M | $5.6M | $5.3M | $5.5M | ||||
| Operating Lease Liability Noncurrent | $21.9M | $22.9M | $24.0M | $26.0M | $27.0M | $27.7M | $27.0M | $28.1M | $29.2M | $31.2M | $32.2M | $4.1M | $4.9M | $5.4M | $5.7M | $4.2M | $4.4M | $4.6M | $5.1M | $5.3M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.7M | $1.8M | $674.0K | $5.9M | ||||||||||||||||||||
| Long Term Debt Noncurrent | $15.0M | $20.0M | $32.0M | $35.8M | $39.2M | $42.3M | $56.3M | $58.1M | $15.1M | $15.1M | $15.0M | $10.0M | $10.0M | |||||||||||
| Increase Decrease Operating Lease Right Of Use Asset | -$935.0K | -$1.8M | -$988.0K | -$373.0K | ||||||||||||||||||||
| Stock Issued During Period Value Under Equity Plan | $585.0K | $682.0K | $609.0K | $411.0K | $515.0K | |||||||||||||||||||
| Equity Method Investments | $131.0K | $670.0K | $920.0K | $1.2M | $100.0K | $303.0K | ||||||||||||||||||
| Repayments Of Debt | $27.4M | |||||||||||||||||||||||
| Other Liabilities Noncurrent | $976.0K | $1.3M | $1.7M | $3.7M | $1.4M | $878.0K | $358.0K | |||||||||||||||||
| Long Term Debt Current | $27.7M | $27.0M | $24.3M | |||||||||||||||||||||
| Restricted Cash Current | $55.0M | $55.0M | $38.5M | $55.0M | $55.0M | $55.0M | ||||||||||||||||||
| Restricted Cash | $55.0M | $55.0M | $55.0M | $35.0M | $55.0M | |||||||||||||||||||
| Non Cash Asset Disposal | $473.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $25.4M | $38.0M | $34.6M | $30.6M | $28.9M | $6.8M | $2.0M | $1.3M |
| Payments To Acquire Property Plant And Equipment | $230.0K | $648.0K | $2.9M | $7.7M | $3.4M | $1.7M | $818.0K | $1.5M |
| Net Cash Provided By Used In Operating Activities | -$74.3M | -$59.7M | -$18.1M | $32.0M | -$135.0M | -$42.9M | -$6.4M | -$20.8M |
| Net Cash Provided By Used In Investing Activities | -$230.0K | -$648.0K | -$2.9M | -$7.7M | -$3.4M | -$1.7M | -$818.0K | $22.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$5.0M | $2.5M | -$1.2M | $3.6M | $2.3M | $2.0M | $120.0K | -$421.0K |
| Increase Decrease In Contract With Customer Liability | -$23.9M | -$55.2M | $38.6M | -$14.7M | $32.8M | $7.0M | $9.0M | $159.0K |
| Increase Decrease In Accrued Liabilities | -$15.3M | $5.9M | -$588.0K | $9.4M | $4.1M | $11.3M | $1.7M | $1.7M |
| Increase Decrease In Accounts Receivable | $1.6M | -$28.1M | $29.3M | -$603.0K | $1.2M | -$54.0K | -$2.3M | $4.0M |
| Increase Decrease In Accounts Payable | -$3.0M | $1.9M | -$2.2M | -$3.1M | -$769.0K | $4.8M | $3.2M | $578.0K |
| Net Cash Provided By Used In Financing Activities | $13.4M | $5.4M | -$24.1M | -$2.9M | $48.0M | $436.1M | $41.9M | $10.2M |
| Proceeds From Stock Options Exercised | $1.1M | $4.7M | $2.7M | $1.7M | $902.0K | $2.7M | $139.0K | $332.0K |
| Increase Decrease In Operating Lease Liability | -$4.2M | -$3.6M | -$4.3M | -$4.5M | -$1.4M | |||
| Proceeds From Stock Plans | $585.0K | $682.0K | $609.0K | $411.0K | $515.0K | |||
| Proceeds From Issuance Of Debt | $15.0M | $20.0M | $46.6M | |||||
| Proceeds From Issuance Of Common Stock | $11.7M | $423.8M | $21.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $6.7M | $10.1M | $8.2M | $7.4M | $7.0M | $849.0K | $399.0K |
| Payments To Acquire Property Plant And Equipment | $137.0K | $240.0K | $691.0K | $2.1M | $118.0K | $142.0K | $78.0K |
| Net Cash Provided By Used In Operating Activities | -$35.1M | -$5.6M | -$35.9M | -$49.0M | -$43.0M | -$11.9M | -$5.4M |
| Net Cash Provided By Used In Investing Activities | -$137.0K | -$240.0K | -$691.0K | -$2.1M | -$118.0K | -$142.0K | -$78.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.2M | -$2.2M | -$4.5M | -$1.5M | -$1.6M | $1.2M | $291.0K |
| Increase Decrease In Contract With Customer Liability | -$9.8M | -$4.0M | $10.3M | -$3.7M | -$1.4M | -$1.7M | $1.1M |
| Increase Decrease In Accrued Liabilities | -$8.2M | $2.3M | $986.0K | -$3.6M | $7.1M | $1.7M | -$2.1M |
| Increase Decrease In Accounts Receivable | $10.6M | -$5.0M | $89.7M | $324.0K | -$118.0K | $172.0K | -$24.0K |
| Increase Decrease In Accounts Payable | -$1.0M | $3.9M | $11.8M | -$44.0K | -$5.4M | -$2.3M | $1.6M |
| Net Cash Provided By Used In Financing Activities | $15.2M | $2.2M | -$27.4M | $336.0K | $47.0M | $118.0K | |
| Proceeds From Stock Options Exercised | $195.0K | $2.2M | $336.0K | $413.0K | $118.0K | ||
| Increase Decrease In Operating Lease Liability | -$1.0M | -$991.0K | -$1.0M | -$445.0K | |||
| Proceeds From Stock Plans | |||||||
| Proceeds From Issuance Of Debt | $15.0M | $46.6M | |||||
| Proceeds From Issuance Of Common Stock |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.40 | -$3.00 | -$1.12 | $0.35 | -$7.74 | -$3.55 | -$2.15 | -$2.16 |
| Common Stock Shares Authorized | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 30.0M | 30.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.3M | 20.3M | 12.1M | 10.1M | ||||
| Common Stock Shares Outstanding | 28.4M | 27.0M | 26.8M | 26.6M | 26.4M | 26.2M | 15.1M | 10.7M |
| Common Stock Shares Issued | 28.4M | 27.0M | 26.8M | 26.6M | 26.4M | 26.2M | 15.1M | 10.8M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.07 |
| Weighted Average Number Of Shares Outstanding Basic | 27.4M | 27.0M | 26.6M | 26.4M | 26.3M | |||
| Weighted Average Number Of Diluted Shares Outstanding | 27.4M | 27.0M | 26.6M | 27.1M | 26.3M | |||
| Earnings Per Share Basic | $-2.40 | $-3.00 | $-1.12 | $0.35 | $-7.74 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.49 | -$0.34 | -$0.52 | -$0.26 | -$0.64 | -$1.00 | -$0.61 | -$1.98 | $1.87 | -$1.33 | -$0.82 | -$1.94 | -$1.47 | -$2.05 | -$2.07 | -$2.15 | -$1.25 | -$0.92 | -$0.55 | -$0.67 | -$0.76 | -$0.56 | -$0.07 | -$0.68 | -$0.42 | -$0.99 |
| Common Stock Shares Authorized | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 60.0M | 30.0M | 30.0M | 30.0M | 30.0M | 30.0M | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 26.4M | 26.4M | 26.3M | 26.3M | 26.2M | 24.9M | 22.9M | 18.8M | 14.5M | 14.5M | 13.2M | 10.4M | 10.1M | 10.1M | 10.1M | |||||||||||
| Common Stock Shares Outstanding | 27.2M | 27.1M | 27.1M | 27.0M | 27.1M | 26.7M | 26.6M | 26.6M | 26.5M | 26.4M | 26.4M | 26.3M | 26.3M | 26.3M | 24.5M | 20.6M | 15.2M | 15.1M | 13.1M | |||||||
| Common Stock Shares Issued | 27.2M | 27.1M | 27.1M | 27.1M | 27.0M | 26.9M | 26.7M | 26.6M | 26.6M | 26.5M | 26.4M | 26.4M | 26.3M | 26.3M | 26.3M | 24.5M | 20.6M | 15.2M | 15.1M | 13.1M | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 27.2M | 27.1M | 27.1M | 27.1M | 27.0M | 26.9M | 26.6M | 26.6M | 26.6M | 26.5K | 26.4K | 26.4K | 26.3M | 26.3M | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 27.2M | 27.1M | 27.1M | 27.1M | 27.0M | 26.9M | 26.6M | 26.6M | 27.1M | 26.5K | 26.4K | 26.4K | 26.3M | 26.3M | ||||||||||||
| Earnings Per Share Basic | $-0.49 | $-0.34 | $-0.52 | $-0.26 | $-0.64 | $-1.00 | $-0.61 | $-1.98 | $1.91 | $-1.33 | $-0.82 | $-1.94 | $-2.05 | $-2.07 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.4M | $38.0M | $34.6M | $30.6M | $28.9M | $6.8M | $2.0M | $1.3M |
| Stock Issued During Period Value Stock Options Exercised | $1.1M | $4.7M | $2.7M | $1.7M | $902.0K | $2.7M | $139.0K | $371.0K |
| Depreciation And Amortization | $3.0M | $3.5M | $3.0M | $1.5M | $1.2M | $882.0K | $684.0K | $582.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $382.0K | -$471.0K | -$229.0K | -$598.0K | $584.0K | |||
| Additional Paid In Capital | $728.5M | $689.8M | $646.4M | $608.4M | $575.7M | $540.3M | $97.4M | $58.3M |
| Capital Expenditures Incurred But Not Yet Paid | $68.0K | $573.0K | $53.0K | $169.0K | $240.0K | $30.0K | ||
| Interest Paid Net | $2.1M | $813.0K | $684.0K | $751.0K | $691.0K | $146.0K | ||
| Foreign Currency Transaction Gain Loss Realized | -$382.0K | -$471.0K | -$90.0K | -$375.0K | $577.0K | |||
| Other Noncash Income Expense | -$502.0K | -$2.2M | -$2.0M | -$162.0K | -$873.0K | -$38.0K | ||
| Stock Issued During Period Value New Issues | $11.7M | $423.8M | $21.3M | |||||
| Stock Issued During Period Value Acquisitions | $5.0M | |||||||
| Stock Issued During Period Shares Stock Options Exercised | 103.4K | 228.3K | 237.8K | 161.3K | 93.2K | 394.7K | 24.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.7M | $6.2M | $6.7M | $9.5M | $9.4M | $10.1M | $9.3M | $8.4M | $8.2M | $9.4M | $7.3M | $7.4M | $6.9M | $7.5M | $7.0M | $2.0M | $1.1M | $849.0K | $383.0K | $403.0K | $399.0K | $587.0K | $140.0K |
| Stock Issued During Period Value Stock Options Exercised | $640.0K | $274.0K | $195.0K | $11.0K | $2.4M | $2.2M | $1.2M | $94.0K | $369.0K | $257.0K | $336.0K | $177.0K | $82.0K | $413.0K | $645.0K | $698.0K | $118.0K | $49.0K | $1.0K | $20.0K | $47.0K | ||
| Depreciation And Amortization | $800.0K | $800.0K | $801.0K | $900.0K | $900.0K | $904.0K | $800.0K | $700.0K | $578.0K | $400.0K | $400.0K | $224.0K | $300.0K | $300.0K | $307.0K | $200.0K | $200.0K | $182.0K | $200.0K | $200.0K | $172.0K | $200.0K | $100.0K |
| Foreign Currency Transaction Gain Loss Before Tax | -$170.0K | -$127.0K | -$21.0K | -$201.0K | -$388.0K | -$53.0K | $4.0K | $149.0K | -$328.0K | $1.9M | $1.2M | $158.0K | $506.0K | -$13.0K | $430.0K | ||||||||
| Additional Paid In Capital | $710.0M | $703.1M | $696.6M | $680.6M | $670.5M | $658.6M | $636.2M | $625.1M | $616.6M | $601.1M | $590.9M | $583.4M | $567.9M | $560.4M | $552.7M | $374.3M | $185.1M | $98.4M | $96.6M | $74.9M | |||
| Capital Expenditures Incurred But Not Yet Paid | $107.0K | $238.0K | $262.0K | $135.0K | |||||||||||||||||||
| Interest Paid Net | $2.1M | $169.0K | $169.0K | $228.0K | $167.0K | ||||||||||||||||||
| Foreign Currency Transaction Gain Loss Realized | -$21.0K | -$53.0K | -$160.0K | $158.0K | $440.0K | ||||||||||||||||||
| Other Noncash Income Expense | -$502.0K | -$546.0K | -$696.0K | -$274.0K | -$212.0K | ||||||||||||||||||
| Stock Issued During Period Value New Issues | $186.6M | $75.3M | $21.3M | ||||||||||||||||||||
| Stock Issued During Period Value Acquisitions | $5.0M | ||||||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 125.0K |
Most recent annual filing with the SEC: March 3, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.